Further characterization of human glucocorticoid receptor mutants, R477H and G679S, associated with primary generalized glucocorticoid resistance

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 73, Issue 3, 2013, Pages 203-207

  Ruiz, Mini ^a   Hedman, Erik ^a   Gåfvels, Mats ^b   Eggertsen, Gösta ^b   Werner, Sigbritt ^a   Wahrenberg, Hans ^a   Wikström, Ann Charlotte ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adrenal; Endocrine physiology; Endocrinology; Hormones of the adrenal cortex; Humans; Internal medicine; Medical biochemistry; Medical physiology; Mutation; Receptors glucocorticoid genetics

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DNA BINDING; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION; GENETIC RESISTANCE; GENETIC TRANSFECTION; GLUCOCORTICOID RECEPTOR GENE; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BINDING SITES; CERCOPITHECUS AETHIOPS; COS CELLS; DEXAMETHASONE; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EXONS; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; METABOLISM, INBORN ERRORS; NF-KAPPA B; POINT MUTATION; PROTEIN BINDING; RECEPTORS, GLUCOCORTICOID; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876125792     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2013.764573     Document Type: Article

References (28)

1. Grad I, Picard D. The glucocorticoid responses are shaped by molecular chaperones. Mol Cell Endocrinol 2007; 275 : 2-12
2. Pratt W B, G aligniana M D, H arrell J M, D eFranco D B. R ole of hsp90 and the hsp90-binding immunophilins in signalling protein movement. Cell Signal 2004; 16 : 857-72
3. Savory J G, Hsu B, L aquian I R, Giffin W, Reich T, H ache R J, Lefebvre YA. Discrimination between NL1-And NL2-mediated nuclear localization of the glucocorticoid receptor. Mol Cell Biol 1999; 19 : 1025-37
4. Beato M, S anchez-Pacheco A. I nteraction of steroid hormone receptors with the transcription initiation complex. Endocr Rev 1996; 17 : 587-609
5. De Bosscher K, V anden Berghe W, H aegeman G. The interplay between the glucocorticoid receptor and nuclear factorkappaB or activator protein-1: Molecular mechanisms for gene repression. Endocr Rev 2003; 24 : 488-522
6. Liden J, D elaunay F, R after I, G ustafsson J, O kret S. A new function for the C-Terminal zinc fi nger of the glucocorticoid receptor. Repression of RelA transactivation. J Biol Chem 1997; 272 : 21467-72
7. Lamberts SW, K oper J W, B iemond P, d en Holder FH, de Jong FH. Cortisol receptor resistance: The variability of its clinical presentation and response to treatment. J Clin Endocrinol Metab 1992; 74 : 313-21
8. Nawata H, S ekiya K, H iguchi K, K ato K, I bayashi H. Decreased deoxyribonucleic acid binding of glucocorticoidreceptor complex in cultured skin fi broblasts from a patient with the glucocorticoid resistance syndrome. J Clin Endocrinol Metab 1987; 65 : 219-26
9. Werner S, B ronnegard M. M olecular basis of glucocorticoid-resistant syndromes. Steroids 1996; 61 : 216-21
10. Brufsky AM, M alchoff D M, J avier E C, R eardon G, Rowe D, Malchoff CD. A glucocorticoid receptor mutation in a subject with primary cortisol resistance. Trans Assoc Am Physicians 1990; 103 : 53-63
11. Hurley DM, Accili D, Stratakis CA, Karl M, Vamvakopoulos N, Rorer E, Constantine K, Taylor SI, Chrousos GP. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest 1991; 87 : 680-6
12. Karl M, L amberts SW, D etera-Wadleigh SD, E ncio IJ, Stratakis CA, Hurley DM, Accili D, Chrousos GP. Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J Clin Endocrinol Metab 1993; 76 : 683-9
13. Malchoff CD, J avier EC, M alchoff DM, M artin T, R ogol A, Brandon D, Loriaux DL, Reardon GE. Primary cortisol resistance presenting as isosexual precocity. J Clin Endocrinol Metab 1990; 70 : 503-7
14. Malchoff DM, B rufsky A, R eardon G, M cDermott P, Javier EC, Bergh CH, Rowe D, Malchoff CD. A mutation of the glucocorticoid receptor in primary cortisol resistance. J Clin Invest 1993; 91 : 1918-25
15. Ruiz M, L ind U, G afvels M, E ggertsen G, C arlstedt-Duke J, Nilsson L, Holtmann M, Stierna P, Wikstrom AC, Werner S. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin Endocrinol (Oxf) 2001; 55 : 363-71
16. Vottero A, K ino T, C ombe H, L ecomte P, C hrousos GP. A novel, C-Terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators. J Clin Endocrinol Metab 2002; 87 : 2658-67
17. Charmandari E, K ino T, I chijo T, J ubiz W, M ejia L, Z achman K, Chrousos GP. A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance. J Clin Endocrinol Metab 2007; 92 : 3986-90
18. Charmandari E, R aji A, K ino T, I chijo T, T iulpakov A, Zachman K, Chrousos GP. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: The importance of the C terminus of hGR LBD in conferring transactivational activity. J Clin Endocrinol Metab 2005; 90 : 3696-705
19. Karl M, L amberts S W, K oper J W, K atz D A, H uizenga N E, Kino T, Haddad BR, Hughes MR, Chrousos GP. Cushing s disease preceded by generalized glucocorticoid resistance: Clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc Assoc Am Physicians 1996; 108 : 296-307
20. Kino T, S tauber RH, R esau JH, P avlakis GN, C hrousos GP. Pathologic human GR mutant has a transdominant negative effect on the wild-Type GR by inhibiting its translocation into the nucleus: Importance of the ligand-binding domain for intracellular GR traffi cking. J Clin Endocrinol Metab 2001; 86 : 5600-8
21. Mendonca B B, L eite M V, d e Castro M, K ino T, E lias L L, Bachega TA, Arnhold IJ, Chrousos GP, Latronico AC. Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene. J Clin Endocrinol Metab 2002; 87 : 1805-9
22. Charmandari E. P rimary generalized glucocorticoid resistance and hypersensitivity. Horm Res Paediatr 2011; 76 : 145-55
23. Kunkel TA, R oberts J D, Z akour R A. R apid and effi cient site-specifi c mutagenesis without phenotypic selection. Methods Enzymol 1987; 154 : 367-82
24. McClary JA, W itney F, G eisselsoder J. E ffi cient site-directed in vitro mutagenesis using phagemid vectors. Biotechniques 1989; 7 : 282-9
25. Charmandari E, K ino T, I chijo T, Z achman K, A latsatianos A, Chrousos GP. Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRalphaR477H and hGRalphaG679S associated with generalized glucocorticoid resistance. J Clin Endocrinol Metab 2006; 91 : 1535-43
26. Wang Z, F rederick J, G arabedian MJ. D eciphering the phosphorylation code of the glucocorticoid receptor in vivo. J Biol Chem 2002; 277 : 26573-80
27. Nader N, B achrach B E, H urt D E, G ajula S, P ittman A, Lescher R, Kino T. A novel point mutation in helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligandbinding domain. J Clin Endocrinol Metab 2010; 95 : 2281-5
28. Ito K, Y amamura S, E ssilfi e-Quaye S, C osio B, I to M, Barnes PJ, Adcock IM. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NFkappaB suppression. J Exp Med 2006; 203 : 7-13